West Pharmaceutical Services Profit Margin 2006-2018 | WST

Current and historical gross margin, operating margin and net profit margin for West Pharmaceutical Services (WST) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. West Pharmaceutical Services net profit margin as of September 30, 2018 is 9.06%.
West Pharmaceutical Services Annual Profit Margins
West Pharmaceutical Services Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $7.982B $1.599B
West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products. West is the world's premiere provider of standard-setting systems and device components for parenterally administered medicines and an emerging leader in the development of advanced formulation technologies for the transmucosal delivery of drugs. West contract manufacturing harnesses a powerful combination of innovation, technology, infrastructure and expertise to serve the pharmaceutical, medical and consumer industries. Along with more than 50 years of experience, they bring customers quality, safety and reliability in injection molding, contract assembly and finished packaging.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $63.191B 21.47
McKesson (MCK) United States $24.096B 9.20
AmerisourceBergen (ABC) United States $17.637B 12.84
Align Technology (ALGN) United States $17.540B 44.75
Cardinal Health (CAH) United States $16.008B 10.75
Laboratory Of America Holdings (LH) United States $14.212B 12.86
Henry Schein (HSIC) United States $12.976B 21.33
Cooper (COO) United States $12.517B 22.11
DENTSPLY SIRONA (XRAY) United States $8.484B 16.94
Merit Medical Systems (MMSI) United States $3.220B 38.14
Patterson (PDCO) United States $2.210B 16.86
CONMED (CNMD) United States $1.902B 31.59
STAAR Surgical (STAA) United States $1.600B 164.82
Atrion (ATRI) United States $1.430B 40.87
Antares Pharma (ATRS) United States $0.503B 0.00
Lifevantage (LFVN) United States $0.210B 29.74
Invacare (IVC) United States $0.173B 0.00
Endologix (ELGX) United States $0.067B 0.00
Pro-Dex (PDEX) United States $0.058B 25.77
Aceto (ACET) United States $0.045B 0.00
Retractable Technologies (RVP) United States $0.021B 0.00
Biolase (BIOL) United States $0.021B 0.00
Milestone Scientific (MLSS) United States $0.018B 0.00